WealthBridge Investment Counsel Inc. lessened its position in Gilead Sciences, Inc. (NASDAQ:GILD – Free Report) by 6.4% in the 2nd quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 64,955 shares of the biopharmaceutical company’s stock after selling 4,450 shares during the quarter. Gilead Sciences makes up [...]
Gilead Sciences, Inc. $GILD Shares Sold by WealthBridge Investment Counsel Inc.
